Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Psychiatric Inpatients
NCT03809897Phase 4Withdrawn
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jan 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline + nicotine patch in nicotine dependence, sponsored by Vall d'Hebron Research Institute. Planned start Jan 2019; status: withdrawn.
02
Drugs
varenicline + nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03809897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809897.